Summary
Risa Mashimo is a clinical pharmacologist at Boehringer Ingelheim with eight years of scientific engagement and an MSci in Biomedicine (First Class) from Lancaster University. Driven by a long-standing passion for drug development, she focuses on oncology, immunology, and genetics and enjoys dissecting mechanisms of action to translate science into patient impact. Her early industry exposure at GSK—where she designed a mock clinical trial in secondary school—helped shape her practical appreciation for trial design and regulatory thinking. Based in Japan, she combines rigorous academic training with hands-on clinical pharmacology work at a global pharmaceutical company, bringing both curiosity and a patient-centered mindset to R&D.
8 years of coding experience
Biology A* / Chemistry A* / Mathematics A*, Biology A* / Chemistry A* / Mathematics A* at Christ's Hospital School
Master of Science - MSci, Biomedicine, First class honour, Master of Science - MSci, Biomedicine, First class honour at Lancaster University
Japanese, English